Be part of the knowledge.™

Groundbreaking MS Research

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Dr. John Richert speaks about the genome abnormality in multiple sclerosis. The etiology is in early discovery stage and leading towards what he describes as the Three Cures.

John Richert, MD

John Richert, MD

Maurice Pickard, MD

Maurice Pickard, MD

Recommended

Details

Presenters

Overview
Dr. John Richert speaks about the genome abnormality in multiple sclerosis. The etiology is in early discovery stage and leading towards what he describes as the Three Cures.

John Richert, MD

John Richert, MD

Maurice Pickard, MD

Maurice Pickard, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway

Phase 3 study results of plozasiran in patients with FCS

FCS and SHTG: Are We Meeting the Need?

$IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement$

IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement

IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis

CME/CE Broadcast Replay

Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference

Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow

FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure